These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12370065)
1. Dimeric 4-Aryl-1,4-dihydropyridines: development of a third class of nonpeptidic HIV-1 protease inhibitors. Hilgeroth A Mini Rev Med Chem; 2002 Jun; 2(3):235-45. PubMed ID: 12370065 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors. Hilgeroth A; Lilie H Eur J Med Chem; 2003 May; 38(5):495-9. PubMed ID: 12767599 [TBL] [Abstract][Full Text] [Related]
3. Cage dimeric N-acyl- and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors. Hilgeroth A; Billich A Arch Pharm (Weinheim); 1999 Nov; 332(11):380-4. PubMed ID: 10605378 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors. Hilgeroth A; Wiese M; Billich A J Med Chem; 1999 Nov; 42(22):4729-32. PubMed ID: 10579836 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors. Hilgeroth A; Billich A; Lilie H Eur J Med Chem; 2001 Apr; 36(4):367-74. PubMed ID: 11461762 [TBL] [Abstract][Full Text] [Related]
6. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells. Hilgeroth A; Langner A Arch Pharm (Weinheim); 2000 Jan; 333(1):32-4. PubMed ID: 10675987 [TBL] [Abstract][Full Text] [Related]
7. Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors. Hilgeroth A; Billich A Arch Pharm (Weinheim); 1999 Jan; 332(1):3-5. PubMed ID: 10073137 [No Abstract] [Full Text] [Related]
8. Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. Thaisrivongs S; Watenpaugh KD; Howe WJ; Tomich PK; Dolak LA; Chong KT; Tomich CC; Tomasselli AG; Turner SR; Strohbach JW J Med Chem; 1995 Sep; 38(18):3624-37. PubMed ID: 7658450 [TBL] [Abstract][Full Text] [Related]
10. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. Ghosh AK; Chapsal BD; Weber IT; Mitsuya H Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874 [TBL] [Abstract][Full Text] [Related]
11. Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: a molecular modeling study. Hilgeroth A; Fleischer R; Wiese M; Heinemann FW J Comput Aided Mol Des; 1999 May; 13(3):233-42. PubMed ID: 10216831 [TBL] [Abstract][Full Text] [Related]
12. Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Luna B; Townsend MU Clin Ther; 2007 Nov; 29(11):2309-18. PubMed ID: 18158073 [TBL] [Abstract][Full Text] [Related]
16. GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro. Koh Y; Das D; Leschenko S; Nakata H; Ogata-Aoki H; Amano M; Nakayama M; Ghosh AK; Mitsuya H Antimicrob Agents Chemother; 2009 Mar; 53(3):997-1006. PubMed ID: 18955518 [TBL] [Abstract][Full Text] [Related]
17. Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerization. Vidu A; Dufau L; Bannwarth L; Soulier JL; Sicsic S; Piarulli U; Reboud-Ravaux M; Ongeri S ChemMedChem; 2010 Nov; 5(11):1899-906. PubMed ID: 20936621 [TBL] [Abstract][Full Text] [Related]
18. Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure. Romines KR; Watenpaugh KD; Howe WJ; Tomich PK; Lovasz KD; Morris JK; Janakiraman MN; Lynn JC; Horng MM; Chong KT J Med Chem; 1995 Oct; 38(22):4463-73. PubMed ID: 7473573 [TBL] [Abstract][Full Text] [Related]